Product Information
OFLOXACIN 0.3% EAR DROPS is a generic product labeled by Caplin Steriles Limited, priced at $0.9789 per ML under NDC 65145014401. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Jan 5, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Caplin Steriles LimitedNDC
65145014401
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217903FDA Approved
1/5/2024
TE Code
AT
On Market Since
12/16/2024
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EAR DROPS has been published 52 times since Oct 8, 2025, and over the history we have for it it has declined 20.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9789 per ML |
|---|---|
| All-time high | $1.2312 (Oct 15, 2025) |
| All-time low | $0.9468 (May 20, 2026) |
| 52-week high | $1.2312 |
| 52-week low | $0.9468 |
| Median price | $1.0395 |
| Average price | $1.0535 |
| Largest weekly change | -6.9% (Apr 22, 2026) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ofloxacin Otic solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Caplin Steriles Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ofloxacin Otic solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EAR DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EAR DROPS, manufactured by Caplin Steriles Limited, is $0.9789 per ML (NDC 65145014401), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EAR DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EAR DROPS has declined 20.5%. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EAR DROPS?
Since Oct 8, 2025, the NADAC for OFLOXACIN 0.3% EAR DROPS has ranged from a low of $0.9468 (May 20, 2026) to a high of $1.2312 (Oct 15, 2025), with a median of $1.0395 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EAR DROPS?
No other NADAC-published product currently shares the active ingredient and strength of OFLOXACIN 0.3% EAR DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OFLOXACIN 0.3% EAR DROPS?
OFLOXACIN 0.3% EAR DROPS (NDC 65145014401) is labeled by Caplin Steriles Limited, and CMS classifies it as a generic product.